Bicycle Therapeutics
BCYC
95 hedge funds and large institutions have $759M invested in Bicycle Therapeutics in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 17 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
76% more call options, than puts
Call options by funds: $600K | Put options by funds: $341K
30% more capital invested
Capital invested by funds: $586M → $759M (+$173M)
5.43% less ownership
Funds ownership: 85.93% → 80.5% (-5.4%)
6% less funds holding
Funds holding: 101 → 95 (-6)
12% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 33
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$67M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$6.67M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$4.49M |
| 4 |
DFO
Duquesne Family Office
New York
|
+$4.04M |
| 5 |
AC
Armistice Capital
New York
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$35.2M |
| 2 |
Morgan Stanley
New York
|
-$11.5M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
-$9.78M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$8.49M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$7.59M |
BCYC Hedge Fund Activity: Q1 2024 in Review
95 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2024, worth a combined $759M — up 30% from $586M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of BCYC and 13 opened new positions — a net loss of 4 holders — while 33 trimmed existing stakes and 29 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $67M. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $35.2M sold.
- 95 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2024, down from 101 in Q4 2023.
- Funds reported $759M of Bicycle Therapeutics stock for Q1 2024, up 30% quarter-over-quarter.
- 13 funds opened new Bicycle Therapeutics positions in Q1 2024 and 17 closed out, a net change of -4 holders.
- The largest Bicycle Therapeutics buyer in Q1 2024 was Baker Bros. Advisors, an estimated $67M added.
- The largest Bicycle Therapeutics seller in Q1 2024 was Jefferies Financial Group, an estimated $35.2M sold.
Based on aggregated 13F filings for Q1 2024.